fulvestrant has been researched along with tibolone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Genazzani, AR; Simoncini, T | 1 |
| Brinkhuis, M; Franke, HR; Jansen, GH; Vermes, I; Wolbers, F | 1 |
2 other study(ies) available for fulvestrant and tibolone
| Article | Year |
|---|---|
Tibolone inhibits leukocyte adhesion molecule expression in human endothelial cells.
Topics: Arteriosclerosis; Cell Adhesion Molecules; Cells, Cultured; E-Selectin; Endothelium, Vascular; Estradiol; Estrogen Antagonists; Estrogen Replacement Therapy; Female; Fulvestrant; Gene Expression; Humans; Intercellular Adhesion Molecule-1; Leukocytes; Lipopolysaccharides; Norpregnenes; RNA, Messenger; Vascular Cell Adhesion Molecule-1 | 2000 |
Effects of fulvestrant alone or combined with different steroids in human breast cancer cells in vitro.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dydrogesterone; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Hormone Replacement Therapy; Humans; In Vitro Techniques; Norpregnenes; Progestins; Receptors, Estrogen; RNA, Messenger | 2008 |